Skip to main content

Summary & Timescale of the Data

The data collection period was from 1 January 2016 to 31 December 2018.

26,108 cases were submitted in total, of which 24,924 were from England (7,552 from 2016, 7698 from 2017 & 9044 from 2018); these 26,108 cases came from 206 consultants at 89 NHS sites, and include 2,454 private patients from 101 consultants.

Hospital Episode Statistics (HES) for 2016 to 2018 indicate that there were 24,464 radical prostatectomies undertaken in England under NHS funding during this period, so we collected data on 92% of the radical prostatectomies undertaken in England during this period (this excludes 2318 privately-funded cases).

84% were robot assisted, 8% laparoscopic and 8% open 

Activity by year

YEAR Median per Consultant Range Median per centre Range Final data analysis
2016 39 1 - 191 100 1 - 465  
2017 41 1 - 228 95 1 - 488  
2018 47 1 - 371 126 1 - 685  
All 104 1 - 692 231.5 1 - 1597  

Adverse events

The overall transfusion rate was 0.29%: for England only, it was also 0.29%. In England only, the transfusion rates by technique were: open 1.8%, laparoscopic 0.34% and robotic 0.15%.

21,795 of the entries recorded whether there had been adverse events. The total post-operative complication rate was 6.8% (1,499/21,795). Of these 1,499 cases, 1,429 recorded the Clavien Dindo grade whilst 70 (4.7%) did not. Complications classified as Clavien Dindo Grade III or above were seen in 1.4% of cases.

Timeline for 2016 to 2018 data

6 May 2019 Deadline for submission of data to BAUS
17 May 2019 Summaries of data returned to Consultant contributors for validation
1 Jul 2019 Final deadline for corrections and additional data
Jul / Aug 2019 Data extracted from the web-based database. Once extracted, the data was transferred to a Microsoft Access™ database for validation before being imported into Tableau™ for generation of the analyses
Aug 2019 All contributing surgeons were sent a link to the website so they could check exactly how their data would be presented.
Sep 2019 Data live to public.